Literature DB >> 24739854

Suprasellar salivary gland-like pleomorphic adenoma.

Kun Yao, Zejun Duan, Yu Bian, Mengyang Wang, Xueling Qi1.   

Abstract

Suprasellar salivary gland-Like pleomorphic adenoma is not a common disease and seldom reported so far. We are reporting a case of a 23-year-old man with recurrent suprasellar salivary gland-like pleomorphic adenoma, who underwent an operation of subtotal, subfrontal resection under the wrong pathology diagnosis of benign teratoma in another hospital 4-year-ago. Four years later, he was admitted to our hospital for additional visual loss of the right eye (left, 1.0; right, 0.4) resulting from tumor regrowth. Magnetic resonance imaging revealed that suprasellar extension and compressed optic chiasm resulted in visual disturbance of the patient. The tumor was totally excised and histological examination evidenced the pathological features of intrasellar salivary gland-like pleomorphic adenoma. The patient did not receive any further treatment and he is free from tumor recurrence for 30 months after the operation. From this point of view, clinical prognosis of intrasellar salivary gland-like pleomorphic adenoma was good after total surgical resection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739854     DOI: 10.4103/0377-4929.130926

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

Review 1.  Intrasellar symptomatic salivary gland: case series and literature review.

Authors:  Zhiyong Liu; Yang Zhang; Ridong Feng; Zerong Tian; Yaping Rao; Ya Lu; Jianguo Xu
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

2.  Salivary gland tissues and derived primary and metastatic neoplasms: unusual pitfalls in the work-up of sellar lesions. A systematic review.

Authors:  T Feola; F Gianno; M De Angelis; C Colonnese; V Esposito; F Giangaspero; M-L Jaffrain-Rea
Journal:  J Endocrinol Invest       Date:  2021-05-03       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.